NO20092655L - 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler - Google Patents

2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler

Info

Publication number
NO20092655L
NO20092655L NO20092655A NO20092655A NO20092655L NO 20092655 L NO20092655 L NO 20092655L NO 20092655 A NO20092655 A NO 20092655A NO 20092655 A NO20092655 A NO 20092655A NO 20092655 L NO20092655 L NO 20092655L
Authority
NO
Norway
Prior art keywords
quinolinone
antibacterial agents
quinoxalinone derivatives
quinoxalinone
derivatives
Prior art date
Application number
NO20092655A
Other languages
English (en)
Norwegian (no)
Inventor
Folkert Reck
Bolin Geng
Janelle Comita-Prevoir
Mark Cronin
Andrew Aydon Godfrey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092655(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20092655L publication Critical patent/NO20092655L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20092655A 2006-12-15 2009-07-13 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler NO20092655L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30
PCT/GB2007/004766 WO2008071961A1 (en) 2006-12-15 2007-12-13 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
NO20092655L true NO20092655L (no) 2009-09-02

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092655A NO20092655L (no) 2006-12-15 2009-07-13 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler

Country Status (17)

Country Link
EP (1) EP2121702A1 (ja)
JP (1) JP2010513255A (ja)
KR (1) KR20090090385A (ja)
AR (1) AR064369A1 (ja)
AU (1) AU2007331247B2 (ja)
BR (1) BRPI0720236A2 (ja)
CA (1) CA2671485A1 (ja)
CL (1) CL2007003641A1 (ja)
CO (1) CO6190619A2 (ja)
EC (1) ECSP099506A (ja)
MX (1) MX2009006325A (ja)
NO (1) NO20092655L (ja)
PE (1) PE20081511A1 (ja)
RU (1) RU2009126731A (ja)
TW (1) TW200831517A (ja)
UY (1) UY30788A1 (ja)
WO (1) WO2008071961A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (ja) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TWI436999B (zh) 2008-10-10 2014-05-11 Actelion Pharmaceuticals Ltd 唑啶基抗生素
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
EP2646567A4 (en) * 2010-10-04 2014-03-26 British Columbia Cancer Agency DETECTION OF FUSOBACTERIUM IN A GASTROINTESTINAL SAMPLE TO DIAGNOSE GASTROINTESTINAL CANCER
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases
BR112020003477A2 (pt) 2017-08-21 2020-08-25 Acadia Pharmaceuticals, Inc. compostos e método para tratar uma doença

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (ja) * 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
CN101454319B (zh) * 2006-05-26 2012-06-27 富山化学工业株式会社 新杂环化合物或其盐及其中间体
WO2008006648A1 (en) * 2006-06-09 2008-01-17 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
JP5315239B2 (ja) * 2006-07-20 2013-10-16 グラクソ グループ リミテッド Ｎ−エチルキノロンおよびｎ−エチルアザキノロンの誘導体およびアナログ

Also Published As

Publication number Publication date
WO2008071961A1 (en) 2008-06-19
CL2007003641A1 (es) 2008-09-22
KR20090090385A (ko) 2009-08-25
BRPI0720236A2 (pt) 2013-12-24
AU2007331247B2 (en) 2011-10-20
UY30788A1 (es) 2008-07-31
ECSP099506A (es) 2009-08-28
AU2007331247A1 (en) 2008-06-19
PE20081511A1 (es) 2008-12-12
TW200831517A (en) 2008-08-01
MX2009006325A (es) 2009-07-24
CO6190619A2 (es) 2010-08-19
AR064369A1 (es) 2009-04-01
EP2121702A1 (en) 2009-11-25
WO2008071961A8 (en) 2009-10-22
RU2009126731A (ru) 2011-01-20
JP2010513255A (ja) 2010-04-30
CA2671485A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20074703L (no) Antibakterielle piperidinderivater
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
NO20090628L (no) Pyridizinon derivativater
NO20076648L (no) Novel thiophene derivatives
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
NO20082496L (no) Pyrazinderivater
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20091395L (no) Nye tiofenderivater
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
EA201100503A1 (ru) Глюкозидные производные и их применения
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20084363L (no) 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application